Publications
Updates on the Biological Heterogeneity of Mantle Cell Lymphoma
Andrew Ip 1,2,*,† , Maciej Kabat 3,† , Lindsay Fogel 1,4 , Hassan Alkhatatneh 5 , Jason Voss 2, Amolika Gupta 4,6,Alexandra Della Pia 2
February 27, 2025 11:27 am
Read More »
Publications
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantationfor Myeloid Malignancies
The research addresses the challenge of disease relapse, a primary cause of treatment failure post-hematopoietic stem cell transplantation. By employing next-generation sequencing of cfDNA to monitor donor cell chimerism and minimal residual disease (MRD) early after transplantation, the study identifies patients at increased risk of relapse. This approach allows for potential early intervention with consolidation therapy, aiming to mitigate the risk of treatment failure.
February 13, 2025 11:51 am
7th Annual Hematologic Malignancies Symposium and Genomics Workshop
The 7th Annual Hematologic Malignancies Symposium and Genomics Workshop offers a unique opportunity for healthcare professionals to deepen their understanding of cutting-edge research and clinical advancements in
January 8, 2025 10:51 am
January 8, 2025 10:44 am
January 8, 2025 10:42 am
January 8, 2025 10:40 am
January 8, 2025 10:38 am
January 8, 2025 10:36 am
Innovation
ASH 24 Posters
GTC presented abstracts at ASH 2024 GTC’s posters from 2024 Convention of American Society of Hematology are now available to be downloaded. Please reach out
December 10, 2024 11:39 am
Publications
Liquid biopsy for evaluating mutations & chromosomal aberrations in CSF from patients with primary or metastatic CNS tumors
Just published in The Journal of Liquid Biopsy Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic
December 10, 2024 10:04 am